Simbec-Orion Hosts Successful Symposia at British Embassy in Copenhagen

News|

Attendees from selected biotechnology companies from across the Nordic region were welcomed by the Simbec-Orion team at our symposium hosted at the British Embassy in Copenhagen on 16 May, supported by the UK’s Department of International Trade (DIT). The ‘Clinical Development Plans for Rare Disease and Oncology Therapies to Improve your Net Present Value’ symposium [...]

Talk To Our Experts at BIO, Boston USA, 5 – 7 June

Events|

Ronald Openshaw, Chief Executive Officer, Simbec-Orion Group Doulgas Cookson, SVP Commercial Development, Simbec-Orion Group Ceri Edwards, Associate Managing Director, Simbec Research Alain Thibault, Senior Medical Director, Orion Clinical

Orphan Drug Designation (ODD): Meeting The Unmet Need

Events|

If you missed our live Orphan Drug Designation (ODD) webinar you can view on demand now. Achieving ODD status, is a significant step enabling your product to be licensed faster, cost-efficiently, and achieve market exclusivity for 10 years. Join this 1-hour webinar where the audience will gain a practical overview in the steps to achieve [...]